Le Programme de recherche pancanadien sur le VIH, le vieillissement et le grand âge est un outil
pour guider les prises de décisions de quatre catégories d’intervenants :
1) Agences subventionnaires et comités d’examen des demandes de bourses de recherche
2) Investigateurs principaux et membres des équipes de recherche
3) Décideurs et militants
4) Institutions, établissements de soins et organismes communautaires

The Pan-Canadian Research Agenda on HIV, Aging and Older Adulthood is a tool to guide decision-making by four interested parties:
1) Research Funders and Grant Review Committees
2) Principal Investigators and Research Team Members
3) Policy Makers and Policy Change Advocates
4) Institutions, Residential Care Settings and Community-Based Organizations

We conducted a quasi-randomized controlled trial with our HIVSmart! program in South Africa to evaluate the impact of an App-based, personalized, oral HIV self-testing program. We were able to demonstrate that through our program it was possible to link 99% of our participants to clinical care, detect 1.5 times new HIV infections, and increase referrals to self-test by 5.5 times.

Poster presentation on PANACHE (Preferences and Needs for Aging Care Among HIV-Positive Elderly People) – a communitybased, participatory research program aimed at describing the self-reported healthcare and social support needs and preferences of older people living
with HIV in Ontario, Canada.

Preferences And Needs for Aging Care among HIV-positive Elderly people in Ontario (“PANACHE ON”) is a qualitative community-based participatory research (CBPR) study that conducted community consultations with people aging with HIV at nine community-based organizations in Ontario, Canada to ascertain their preferences and needs for aging care.

This report authored by Realize and the National Coordinating Committee on HIV and Aging (NCC) and the research database, provide a snapshot of the HIV and aging research underway in Canada at a single point in time.

The purpose of this paper is to provide an overview of incarceration and STBBIs, and to provide evidence that correctional facilities in Canada are an essential setting for STBBI care. It includes a summary of risks and factors affecting transmission, and illustrates how movement between facilities and communities is an important factor in STBBI transmission.

This realist review aims to contribute to a greater understanding of the usefulness of STBBI POCT in Canada by highlighting what we found in the literature in terms of the enablers and barriers to implementing STBBI point of care testing. It includes a summary of the evidence regarding feasibility, cost effectiveness, detection of positive cases and early diagnosis, linkage to care, user preference, acceptability and uptake (including traditional serology versus POCT; single versus multiplex tests).

​

For the last 30 years, the CTN has played a central role in driving Canada’s HIV research efforts by uniting researchers to develop treatments, preventions, and a cure for HIV and related health conditions

Interview transcript with Dr. Marc Ouellette, Scientific Director of the CIHR Institute of Infection and Immunity who discusses how Canada is contributing to the global effort to end HIV/AIDS.

Dr. Catherine Worthington, Making Connections School of Public Health and Social Policy

Dr. Worthington’s modus operandi is networking—connecting people and projects in the HIV community to enhance the research experience and the end results. The networks are “open and active,” she explains, “We are trying to promote, mentor, and bring together people from community, research and policy to do ...

Taking Cues from the Community

CTAC Policy Researcher, Adam Cook, discusses the prevalence, cure and accessibility of treatment for people living with hepatitis C in Canada.

Canadian HIV Cure Enterprise and the global effort to conquer HIV

Finding Predictability in the unpredictable

A Pragmatic Science

People and Populations: The HIV and HCV Research

This article presents an epidemiological summary of the active TB disease cases reported from 2006 to 2016, with a focus on 2016. Treatment outcomes for cases diagnosed in 2015 are also presented.

Theoretical frameworks and key concepts within the scope of gay men’s health.

HIV and HCV in Mother and Child

Dr. Hugo Soudeyns, Professor at Université de Montréal and researcher at CHU Sainte-Justine, has been involved with HIV research since the early years of its emergence. He has seen a considerable amount change over this time, from knowing little about the virus at the outset to the ...

What you need to know and what you can do to prevent Antimicrobial resistance in Gonococcal infections

Preventing the spread of extensively drug-resistant gonorrhea

AIDS: Existing Treatments Are Not Effective Enough

Routine surveillance of HIV among pregnant mothers and infants in Canada.

Highlights from the Sex Now survey by province

The Federal Initiative to Address HIV/AIDS in Canada focuses on preventing the spread of HIV/AIDS, slowing its progression, and improving the quality of life of people living with HIV/AIDS. As a horizontal initiative, it leverages a collaborative approach by the Public Health Agency of Canada, Health Canada, the Canadian Institutes of Health Research, and the Correctional Service of Canada, along with provincial and territorial governments, non-governmental organizations, researchers, health care professionals, and people living with, and vulnerable to, HIV/AIDS.

Addressing determinants of STBBI among street-involved youth
Fact Sheet: Experiences with the criminal justice system

Fact Sheet: Access to health services

Fact Sheet: Education and Employment

Sharing research on the effects of HIV-Associated Neurocognitive Disorders (HAND).
Francisco Ibanez-Carrasco interviews an esteemed panel of researchers about recent studies of HIV-Associated Neurocognitive Disorder

Immune Correlates of HIV Susceptibility

Response to CADTH therapeutic review, drugs for chronic hepatitis C infection

This is a report from the Canadian Institutes for Health Research (CIHR) Team for the Study of Acute HIV Infection in Gay Men. It presents data from interviews and questionnaires completed by HIV-negative study partici-pants between June 2011 and March 2013.

Polypharmacy is defined as the concurrent use of five or more medications. This document addresses the issue, risks, and tools for mitigating the effects of polypharmacy among older adults living with HIV

Maggie Atkinson, CAC’s first chair, tells the story of CAC’s formation in 1993, its impact in the early pre-HAART years, and how including this community voice in HIV research changed the power structure between researchers, pharmaceutical companies, and people living with HIV.

Keeping it Quiet: HIV infection and Immune Quiescence

While many Aboriginal communities are climbing out of dark pasts, what remains are significant challenges to retain culture, language, and traditional strengths while seeking to be adaptive to a new era. This report describes some of these challenges. They will help to understand that Survivors have needs, unique and above others in the Aboriginal population, yet they are still ...

Synposes of research studies aimed at tackling key global health challenges to address inequities and disparities in health.

In Canada, chlamydia is the most commonly reported STBBI.

Key findings related to stigma around HIV infection and discrimination towards people living with HIV/AIDS.

Ongoing HIV transmission remains an issue of concern in Canada. The Agency estimates that 2,570 new infections (range between 1,940 and 3,200) occurred in Canada in 2014. This estimate is slightly lower than the estimate for 2011 (2,800; range between 2,100 and 3,500) (Table 1, Figure 1). The estimated incidence rate in Canada in 2014 was 7.2 per 100,000 population (range between 5.5 and 9.0 per 100,000 population).